drugset / Trial / NCT07300956
Treating Young Children With Attention Deficit Hyperactivity Disorder
Phase 4
Not yet recruiting
370 enrolled
Children's Hospital Medical Center, Cincinnati
Boston Children's Hospital, Boston, MA, USA · collabChildren's Hospital of Philadelphia · collabChildren's Mercy Hospital Kansas City · collabDevelopmental Behavioral Pediatrics Research Network · collabPatient-Centered Outcomes Research Institute · collabStanford University · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This project will evaluate the effectiveness of Methylphenidate versus Guanfacine in treating Attention-Deficit/Hyperactivity Disorder (ADHD) in children aged 3 through 5 years (inclusive), as measured by clinician rating of global improvement.
Timeline
- Start
- 2026-02
- Primary completion
- 2030-02
- Completion
- 2030-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Guanfacine | Small molecule | — | — |
| Comparator | Methylphenidate | Small molecule | — | — |